The University of Chicago Header Logo

Connection

Hedy Kindler to Topotecan

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Topotecan.
Hedy Kindler
Connection Strength
0.160
Topotecan
  1. Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer. Am J Clin Oncol. 1998 Oct; 21(5):438-41.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.